Mesothelin and Claudin 18.2 Dual-Target CAR-T Therapy in Advanced Pancreatic Cancer

NCT07066995 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Pancreatic Carcinoma
Pancreatic Cancer Non-resectable
Pancreatic Cancer Stage IV

Interventions

BIOLOGICAL: Mesothelin and Claudin 18.2 CAR-T cells

Sponsor

Essen Biotech